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ABSTRACT 
 Restless Legs Syndrome (RLS) is a disorder characterized by 
disagreeable leg sensations, usually prior to sleep onset, which 
cause an almost irresistible urge to move the legs.  A 
characteristic feature of this disorder is that the movements 
are partially or completely relieved with leg motions.  Attempts 
to find the underlying pathology have been unsuccessful.  Thus, 
there are no objective physiological tests to diagnose this 
condition.  Using the Suggested Immobilization Test (SIT), the 
current study attempted to validate a new and practical method 
for quantifying the motor symptoms of RLS, actigraphy.  To this 
end, the SIT with actigraphy was evaluated for its usefulness as 
either a diagnostic or screening tool using indices of 
sensitivity, specificity, false positive and false negative 
rates, taking base rates into account.  The actigraphic SIT was 
not found to be an effective diagnostic or screening tool.  
Further advancements in actigraph technology and future research 
may eventually provide evidence of an actigraphic SIT being an 
effective screening or diagnostic tool, despite the findings in 
the present study.  Limitations in actigraph technology were 
encountered.  These limitations are described, as well as the 
implications for the current study and similar existing 
research.
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INTRODUCTION 
Restless Legs Syndrome (RLS) is a disorder characterized by 
disagreeable leg sensations, usually prior to sleep onset, which 
cause an almost irresistible urge to move the legs.  A 
characteristic feature of this disorder is that the movements 
are partially or completely relieved with leg motions.  Attempts 
to find the underlying pathology of RLS have been unsuccessful.  
Thus, there are no objective pathophysiological assessments to 
diagnose this condition.  The diagnosis of RLS remains a 
clinical one based on the patient’s self-report of symptoms.  
Identifying any objective means of quantifying RLS 
symptomatology could be used diagnostically and aid in research 
of RLS.  Objective testing could provide for development of 
objective screening tests or aid in comparing participant 
characteristics in research studies. 
Ongoing research is attempting to develop objective tests 
of RLS symptoms.  To that end, two tests have been developed to 
measure the motor restlessness experienced by RLS patients, the 
Suggested Immobilization Test (SIT) and the Forced 
Immobilization Test (FIT).  The ability to use these tests both 
clinically and for research purposes is somewhat limited by the 
specialized equipment and staff time/resources needed to perform 
these.  Thus, the current study aimed to validate a new and more 
practical method for quantifying the motor symptoms of RLS, 
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actigraphy.  Additionally, whether or not the SIT or the FIT has 
adequate sensitivity and specificity to discriminate between RLS 
and normal individuals has proved debatable.  To this end, the 
current study aimed to evaluate the SIT with actigraphy using 
indices of positive and negative predictive values, taking base 
rates into account.   
First, characteristics of RLS identified in research and 
clinical samples will be described in detail and related to 
current diagnostic criteria.  Features and conditions associated 
with RLS will be described.  Then, actigraphy will be discussed, 
with particular emphasis on how this methodology is applicable 
to the assessment of RLS symptoms.  Next, specific research 
findings pertinent to the current study will be described.  
Last, the methodology and findings from the current study are 
detailed. 
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REVIEW OF LITERATURE 
Clinical Features 
Restless Legs Syndrome (RLS), as defined by the ASDA (ASDA, 
1990), is a disorder characterized by disagreeable leg 
sensations, usually prior to sleep onset, that cause an almost 
irresistible urge to move the legs.  The ASDA delineates six 
diagnostic criteria for RLS, the first three of which are 
necessary for a diagnosis.  The criteria are: (1) a complaint of 
an unpleasant sensation in the legs at night or difficulty in 
initiating sleep; (2) disagreeable sensations of “creeping” 
inside the calves often associated with general aches and pains 
in the legs; (3) the discomfort is relieved by movement of the 
legs; (4) polysomnographic monitoring demonstrates leg movements 
at sleep onset; (5) no evidence of any medical or psychiatric 
disorders that account for the leg movements; (6) other sleep 
disorders may be present but do not account for the symptom.   
The ASDA categorizes severity into three categories.  Mild 
refers to symptoms that occur episodically with no more than a 
mild disruption of sleep onset that does not cause the patient 
significant distress.  Moderate RLS refers to symptoms that 
occur less than twice a week, with a significant delay of sleep 
onset, moderate disruption of sleep and mild impairment of 
daytime function.  In severe RLS, the symptoms occur three or 
more times a week, with severe disruption of nighttime sleep 
  4
patterns and marked daytime symptoms.  Also, duration criteria 
are delineated: acute (two weeks or less), subacute (more than 
two weeks but less than three months) and chronic (three months 
or longer).   
RLS patients often have difficulty describing the nature of 
the uncomfortable sensations.  Some terms most often used by 
patients to describe the sensations include “creeping”, 
“crawling”, “itching”, “tingling”, “prickling”, or “pins and 
needles” (ASDA, 1990; Ekbom, 1960; Walters & Hening, 1987).  
Researchers often use the term paresthesias or dysesthesias, 
which simply imply abnormal sensations.  These uncomfortable 
sensations develop or are exacerbated during periods of motor 
inactivity and are relieved by agitated motor activity.  For 
many RLS patients, sleep onset is particularly difficult to 
attain due to the increase in symptoms and symptom severity 
associated with lying still in bed, such that they may have to 
get out of bed and walk to relieve their discomfort.  Pelletier, 
Lorraine and Montplaisir (1992) studied whether the motor 
movements exhibited were a direct consequence of the 
uncomfortable sensory events by examining the temporal 
relationship between these events.  These researchers found that 
while almost all of the sensory events were associated with leg 
movements, determined by a sensory event occurring either 5 
seconds before or after the leg movement, there were some 
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sensory events without motor events.  Additionally, only half 
(49%) of the motor symptoms were associated with sensory events, 
indicating that some were not in an effort to relieve 
discomfort.  Thus, the authors concluded that the sensory and 
motor events in RLS represent independent manifestations of a 
common neural dysfunction. 
RLS symptoms have been found to be worse in the evening or 
at night, and worse when lying or sitting during the day or the 
night (Ekbomb, 1946; Ekbomb, 1960).  Part of this worsening 
appears to be due to the fact that people tend to sit and lie 
down more in the evening hours than during the day.  However, 
there is also evidence for an independent circadian factor 
contributing to the nighttime worsening (Montplaisir, Boucher, 
Gosselin, Gaetan, & LaVigne, 1995; Trenkwalder, et al., 1995).  
Research examining this feature of RLS is discussed later in the 
current paper. 
Another characteristic of RLS relevant to the current study 
is the degree of lateralization of symptoms.  Historically, most 
patients have been reported as having bilateral sensory and 
movement symptoms.  Montplaiser et al. (1997) found that forty-
two percent of patients reported at least some lateralization of 
sensory and motor symptoms to either the right or the left leg.  
Additionally, Montplaiser et al. (1998) found that movements 
were predominantly bilateral (mean index of bilateral 
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movements=52/hour), though there were a number of movements 
exhibited exclusively on the right leg only (mean index=14/hour) 
or on the left leg only (mean index=10/hour).  Of the sixteen 
RLS patients who participated in their study, there was one RLS 
patient for whom the movements were predominantly or exclusively 
exhibited on the right and one whose movements were such on the 
left.  Thus, the above findings confirm that many patients have 
predominantly bilateral movements; however, some patients do 
have some lateralized movements and some patients have 
predominantly lateralized movements. 
Associated Features and Conditions 
Prevalence.  Ekbom (1945) first estimated the prevalence of RLS 
in the normal population as being 5%.  Across studies, the 
prevalence of RLS in the general population has been estimated 
to be from 2-15%; however, definitive data are not available 
(ASDA, 1990).  Much of the variability in the rates described is 
due to vast differences in methodology employed, from face-to-
face interviewing performed by trained professionals (Rothdach, 
Trenkwalder, Haberstock, Keil, Berger, 2000) to a single RLS 
question added to a survey of multiple phenomena (Phillips et 
al., 2000).  Most studies have found rates of approximately five 
percent.   
Age of Onset.  To date there have been no longitudinal studies 
performed to definitively identify the typical age or age range 
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in which RLS develops.  Thus, most studies reporting age of 
onset in RLS are based on retrospective self-report.  Not 
surprisingly, vast differences reported in the literature 
concerning the age of onset of RLS have been largely due to 
methodological differences.  RLS has typically been considered 
to be a disorder of the middle to older age population.  
However, some studies have suggested that this is inaccurate.  
RLS patients in a study by Ondo and Jankovic (1996) reported an 
average age of onset of 34 years, though there was a high degree 
of variability (standard deviation of 20.3).  In another study 
(Walters et al., 1996), more than one third of the RLS patients 
reported experiencing their first symptoms before the age of 10, 
and 43% had their first symptoms before the age of 20.  These 
findings suggest that RLS may not be predominantly a disorder of 
middle age, but a condition that has a much earlier onset than 
previously identified.  One hypothesis suggested for this 
discrepancy is that young persons with the RLS symptoms are 
initially misdiagnosed as experiencing “growing pains” or the 
symptoms were thought to by psychogenic (Walters et al., 1996).  
Additionally, given that the symptoms have often been found to 
increase in severity with age for many individuals, it is 
possible that RLS is present, but not diagnosed, in younger 
individuals who may not present for treatment until the symptoms 
become severe. 
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Clinical Course.  RLS symptoms can have a varied course, with 
some patients reporting that the symptoms increase over time and 
others reporting a constant degree of symptom severity.  Many 
patients report that symptoms remit occasionally.   In a 
questionnaire study of 138 patients with RLS (Walters et al., 
1996), 15% of the patients reported a previous total remission 
of symptoms of a month or more.  Thus, the symptoms may have a 
waxing and waning course, though there have been no findings to 
explain this information. 
Associated Conditions.   Attempts to find biological markers 
have yet to be successful.  Although there have been 
abnormalities identified in some subsets of persons with RLS, 
the sensitivity and the specificity of these has not been 
sufficient for their usefulness as diagnostic markers.  RLS has 
been found to exist at higher than normal rates in a number of 
medical conditions: 11% of pregnant women, 15-20% of uremic 
patients, and up to 30% of patients with rheumatoid arthritis 
(ASDA, 1990).  RLS has often been associated with another, 
related condition, namely periodic limb movement disorder 
(PLMD).  In one study, approximately 80% of RLS patients had co-
morbid PLMD (Montplaisir et al., 1997).  Individuals for whom 
there is no identifiable medical cause of this symptom are 
referred to as having primary or idiopathic RLS.  Individuals 
reporting symptoms of RLS, but with an identified cause are 
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generally referred to as having secondary RLS.  There do not 
appear to be any differences in symptom presentation between the 
primary and secondary forms of the disorder (Walters, 1995). 
Periodicity of Movements while Awake 
One difficulty often encountered in the literature on RLS 
is that the ASDA criteria do not adequately describe the motor 
symptoms of this disorder.  The lack of adequate descriptive 
criteria has led to inconsistent usage of the diagnosis.  For 
example, some researchers have utilized the term RLS as if it 
were a symptom or form of PLMD.  This stems from previous 
beliefs that RLS always occurred in conjunction with PLMD, and 
that a diagnosis of PLMD would support a diagnosis of RLS; a 
PLMS index greater than five or ten has been previously used by 
some as an “objective diagnostic criterion” of RLS (Walters, 
Picchietti, Ehrenberg, Wagner, 1994).  Given the frequency this 
association occurs in the RLS literature, a brief review of the 
clinical characteristics of PLMD is warranted to highlight the 
similarities and differences in these overlapping disorders and 
patient populations.   
Some researchers have used the terms PLMD interchangeably 
with periodic limb movements of sleep (PLMS).  Other researchers 
have used PLMD to refer exclusively to patients meeting the 
diagnostic criteria set forth by the ASDA, and used PLMS to 
refer to the repetitive limb movements that occur during sleep 
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in some individuals without necessarily meeting the diagnostic 
criteria.  For the purposes of this paper, PLMD will refer only 
to those individuals meeting diagnostic criteria for the 
disorder and PLMS will refer to any movements occurring during 
sleep that conform to scoring criteria for periodic limb 
movements (i.e., as opposed to non-periodic movement activity), 
both of which are described in greater detail below. 
PLMD is characterized by periodic episodes of repetitive 
and highly stereotyped movements that occur during sleep at a 
rate of five per hour or greater (i.e., PLMS).  In PLMD, the 
movements do not occur during the day and persons with PLMD may 
or may not experience any daytime symptoms, such as 
hypersomnolence.  Coleman’s criteria (Coleman, 1982) have become 
standard for defining and scoring PLMS.  The criteria allow for 
scoring a limb movement as a PLMS when it occurs as a part of a 
series of at least four consecutive movements that are separated 
by at least 4, but not more than 90 seconds.  Additionally, the 
duration of the movement must be between 0.5 and 5.0 seconds.  A 
PLMS index refers to the average number of PLMS per hour of 
sleep, with an index of more than 5 per hour being pathological 
and qualifying for a PLMD diagnosis.   
Researchers and clinicians, who have conceptualized RLS as 
being a symptom or form of PLMD, postulate that not all persons 
with PLMD have RLS, but that all RLS patients have PLMD.  
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However, research in these populations has documented that while 
many patients with RLS do indeed have PLMS, many do not show 
evidence of PLMD or do not have sufficient PLMS to warrant a 
diagnosis of PLMD (ASDA, 1990).  For example, Montplaiser et al. 
(1997) found that of 133 patients diagnosed with RLS, 20% had 
PLMS index lower than 5 (i.e., PLMS index in the normal range).  
Thus, the PLMS index alone would not be either necessary or 
sufficient to diagnose RLS in patients complaining of sensory 
and motor symptoms associated with periods of inactivity.  PLMD 
represents a nosological and clinical entity that can be 
differentiated from RLS; though these conditions are often 
overlapping, RLS is primarily a problem experienced during 
wakefulness just prior to sleep onset, while PLMD is primarily a 
phenomenon occurring during sleep. 
As described, the predominant symptoms in RLS occur during 
wakefulness.  Involuntary movements similar to PLMS have been 
reported to exist during wakefulness in RLS patients (Brodeur, 
Montplaisir, Godbout, Marinier, 1988; Montplaisir, Godbout, 
Boghen, De Champlain, Young, 1985; Montplaisir & Godbout, 1989; 
Pelliter, Lorrain, & Montplaisir, 1992).  The movements seen in 
PLMD are highly stereotyped movements.  One similarity between 
PLMS and the involuntary movements seen in RLS patients is that 
they are similar in appearance.  Specifically, the movements are 
typically dorsiflexions of the big toe with fanning of the small 
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toes, accompanied by flexions of the ankles, knees and thighs.  
PLMS are, by definition, periodic, but the movements exhibited 
by RLS patients may be either periodic (Pollmacher & Schulz, 
1993; Walters et al., 1988) or aperiodic (Walters, 1995).  The 
involuntary movements while awake occur almost exclusively at 
rest and cease with activity.  Moreover, PLMS are rarely rapid 
enough to be considered myoclonic, while the involuntary 
movements seen in waking RLS patients can be myoclonic, though 
they are often more sustained than PLMS (ASDA, 1990).  Last, 
many of the movements in RLS are voluntary movements intended to 
alleviate paresthesias.  Thus, the movements in RLS both during 
wakefulness seem to be both voluntary and involuntary. 
Relevant Research Findings 
In response to an evident inconsistency in the definition 
of RLS, a large international study group was formed and 
identified essential criteria for the diagnosis of RLS.  The 
study group noted that the ASDA criteria do not adequately 
characterize the motor restlessness in RLS or the involuntary 
motor movements evidenced in RLS patients during periods of 
wakefulness (Walters, 1995).  The group delineated four minimal 
clinical characteristics necessary for the diagnosis: (1) a 
desire to move the limbs, usually associated with 
paresthesia/dysesthesias; (2) motor restlessness (i.e., use of 
various motor activities to relieve the discomfort); (3) 
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symptoms that are worse or exclusively present at rest (e.g., 
lying, sitting) with at least partial and temporary relief by 
activity; (4) symptoms that are worse in the evening or at 
night.  Several other clinical features were identified that are 
commonly seen in RLS patients, though they are not necessary for 
the diagnosis: (1) sleep disturbances and its consequences; (2) 
involuntary movements which could refer to periodic limb or leg 
movements in sleep or involuntary leg movements while awake and 
at rest; (3) no neurological abnormalities in the primary form, 
though these may be present in the secondary form; (4) the 
clinical course is variable, but most of the more severely 
affected patients are middle to older age, and the condition is 
progressive; (5) a familial pattern may be present. 
Researchers (Brodeur et al., 1988; Pelletier, Lorrain, 
Montplaisir, 1992) attempting to quantify the motor symptoms in 
RLS designed two tests, the Forced Immobilization Test (FIT) and 
the Suggested Immobilization Test (SIT).  For the SIT test, 
patients sit or lie motionless on a bed with their legs 
outstretched and eyes closed while electromyogram recordings of 
the anterior tibialis muscles are recorded bilaterally.  This 
test was first employed in 1988 to measure the therapeutic 
effects of L-dopa in RLS patients (Brodeur et al., 1988).  The 
FIT employs greater leg immobilization, where the patient sits 
on a stretcher with both legs immobilized in the extended 
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position.  The stretcher prevents movement of the legs and 
limits the movement of the ankle and the foot.   
Montplaisir et al. (1998) examined the sensitivity and 
specificity of the SIT and the FIT in differentiating sixteen 
RLS patients from sixteen age- and sex- matched control 
subjects.  RLS patients had three times more leg movements 
during the SIT than did normal controls, with a mean of 76 for 
RLS patient versus 27 for controls.  Additionally, both RLS 
patients and controls evidenced more movements during the second 
half of the hour-long test, but the difference was significant 
only in the RLS patients.  On the FIT, RLS patients did have 
more movements than controls, but the difference was 
statistically significant only when comparing each group on the 
second half of the test; the differences between the two groups 
on the first half of the test and on the entire test were not 
statistically significant.  Using receiver-operator 
characteristic curves to obtain cutoff scores, Dawson-Saunders & 
Trapp (1994) suggested that a cutoff of 40 movements per hour on 
the SIT or of 25 movements on the FIT resulted in the highest 
overall sensitivity and specificity of the two tests.  The SIT 
proved to differentiate between the RLS patients and the 
controls better than the FIT, with a sensitivity of 81% and a 
specificity of 81%, compared to 69% and 56%, respectively, for 
the FIT.  The authors posit that the movements exhibited during 
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the SIT may represent combinations of different types of 
movements, both involuntary periodic leg movements and voluntary 
movements to relieve discomfort, and that during the FIT the 
voluntary movements are decreased due to external leg 
restraints; also, the decreased movement may not have allowed 
for as much relief from discomfort and that the patients may 
have not moved as much as a result.  However, they provide no 
evidence to support this claim. 
Two explanations of the finding that RLS symptoms are worse 
in the evening and at night are that either a circadian factor 
modulating these symptoms exists, or that people tend to lay 
down more in the evening and night time hours, or a combination 
of the two.  To examine these hypotheses, Montplaiser et al. 
(1995) conducted a study to examine sensory symptoms and motor 
symptoms in the morning and evening in RLS patients.  The 
researchers utilized the SIT to measure motor symptoms, and 
required the patients to press a button each time they 
experienced a paresthesia in their legs similar to those 
experienced at home, to assess subjective sensory symptoms.  The 
SITs were performed once in the morning and again in the 
evening, with the evening SIT being lengthened from thirty 
minutes to an hour to examine the role that immobility duration 
plays in the severity of motor and sensory symptoms.  The 
results indicated that the duration of the immobility did result 
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in a statistically significant exacerbation of both motor and 
sensory symptoms.  However, neither the sensory nor motor 
symptoms were statistically greater during the evening than the 
morning SIT.  The data suggest that time of day effects may not 
be important in differentiating RLS patients from normal 
controls in relation to motor restlessness, but that it would be 
useful to increase the duration of the SIT recording from 30 to 
60 minutes. 
Researchers utilizing the SIT to measure daytime motor 
restlessness in RLS patients have often used Coleman’s PLMS 
criteria to score movements.  One alteration often employed in 
daytime SIT recording is extending the upper duration limit of 
the movement to 10 seconds because a large number of movements 
during wakefulness exceed 5 seconds (Montplaisir et al., 1998).  
However, it is unclear how appropriate this methodology is given 
that not all movements by RLS patients are involuntary or 
periodic.  Further, it is unknown how the use of PLM criteria to 
score movements affects the sensitivity and specificity of the 
SIT. 
Sleep laboratories rely on a patient’s self-report of 
symptoms to diagnose RLS.  Currently, the only objective 
measures of motor symptoms experienced by persons with RLS are 
the SIT and the FIT.  Prior research on the sensitivity and 
specificity indicates that the SIT has greater promise as an 
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objective means of differentiating normal subjects from 
individuals with RLS.  However, the SIT tests require 
considerable staff time to perform and analyze results.  The 
latter problem also impedes the ability of researchers to 
explore ways to increase the sensitivity and specificity of the 
SIT.  Thus, there is a need for an objective measure of RLS that 
could be completed with minimal staff involvement and/or without 
the use of specialized staff.  The current study attempted to 
evaluate the appropriateness of using actigraphy instead of a 
polygraph to complete a SIT test and examined factors 
potentially related to the ability of the SIT to objectively 
differentiate RLS patients from control subjects (i.e., persons 
without RLS or other movement disorders).  This novel method for 
examining RLS, if validated, could allow for long-term night-to-
night quantification of RLS symptomatology, a task that is not 
feasible with standard polysomnography.  
Actigraphy 
The current study proposed to validate the use of 
actigraphy to examine RLS motor symptoms.  Actigraphs are small, 
portable devices that detect physical motion, generate an 
internal signal each time they are moved, and store that 
information.  They are typically used to measure general or 
random motor restlessness in order to evaluate rest-activity 
cycles.  Actigraph recordings integrate the amplitude values of 
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an actigraphic signal over a defined time period, usually 10, 30 
or 60 seconds, and algorithms can be used to estimate the sleep 
architecture of an individual.  The user can set the frequency 
desired for integrating the amplitude values of the signal to 
produce output from every 2 to every 60 seconds.   
In the area of sleep and sleep disorders, actigraphy is 
typically used to estimate sleep onset and duration based on the 
relative lack of movement activity during sleep.  Actigraphy has 
been shown to best estimate sleep duration, sleep efficiency and 
waking after sleep onset; it is less accurate at estimating 
sleep onset latency (ASDA Report, 1995).  Research evaluating 
the usefulness and validity of actigraphy in RLS and PLMD 
patients, other movement disorders, or insomnia indicates that 
actigraphy provides a poor estimate of sleep parameters.  In all 
of the latter conditions, the patient may be having movements 
while asleep, or may be still while lying awake for a prolonged 
period of time, thereby inaccurately estimating sleep.  However, 
while actigraphy is poor in evaluating the sleep of these 
patient populations, it is not poor at detecting movement.  
Actigraphy provides a measure of general motor activity, 
and may not accurately measure short, distinctive movements like 
PLMS.  In 1995, Kazenwadel et al. studied the reliability and 
validity of using actigraphy to measure periodic limb movements.  
The results showed that there was a high correlation (.91) 
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between the EMG recording and the actigraph recordings, but 
actigraphy did underestimate the number of PLMS, with the 
actigraph recording 30% fewer movements than were identified by 
EMG recordings.  However, one difference between these two 
methodologies may explain the underestimation of PLM activity by 
actigraphy: Recordings of tibialis electromyogram monitor 
movements made by either leg independently or by both legs 
simultaneously, but the study employed the use of one actigraph 
placed on one leg, which is the methodology typically employed 
in actigraphy.  The underestimation of PLM activity by the 
actigraphs may have been due to the use of one actigraph on one 
leg, which may not have been detected unilateral movements on 
the leg opposite the actigraph.  Therefore, this investigation 
did not adequately assess the sensitivity of actigraphy as a 
measure of PLMS.  No investigation to date has attempted to 
evaluate actigraphy as a measure of RLS movements.   
Study Objectives 
The goals and implications for the current study were as 
follows.  First, validate the use of actigraphy to objectively 
quantify motor restlessness in RLS, using the actigraphy and the 
polygraph simultaneously.  Second, determine whether or not 
using PLM criteria to score movements results in significant 
differences in the number of movements identified during the 
SIT.  Third, determine whether or not it would be advantageous 
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to use bilateral actigraphs rather than unilateral to 
approximate polygraph recordings of leg movements.  Fourth, 
evaluate the ability of the SIT to differentiate between normal 
subjects and persons with RLS.  It was hoped that the results 
from the above analyses would provide support for an actigraphic 
SIT test to identify persons with RLS.   
If the actigraphic SIT test was capable of differentiating 
between RLS and normal subjects, this methodology could be used 
as a large-scale screening tool and as a means of longitudinal 
follow-up in sleep medicine research and in clinical sleep 
medicine.  Serial SIT tests would be useful for objectively 
assessing symptom variability across time in the RLS population, 
which is currently not feasible with the use of polygraphic SIT 
tests.  In the following section, the methodology and statistics 
that were used to test these experimental questions are 
described. 
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METHODS 
Participants 
Fifteen subjects for each group, RLS and controls, were 
recruited to participate, for a total of thirty subjects.  RLS 
subjects were volunteers recruited through the Ochsner Clinic of 
Baton Rouge Sleep Disorders Center, through contacts with the 
Restless Legs Foundation and a local support group leader.  RLS 
subjects were not excluded if they had another sleep disorder, 
given that having another sleep pathology would not affect a 
daytime recording or motor activity.  Any RLS subjects being 
treated for RLS or PLMD with medications would have been asked 
to abstain from taking any medications related to their RLS on 
the day of the study; however, none of the participants were 
taking medications at the time of the study.  Since there is no 
difference in the symptom presentation of primary and secondary 
RLS, conditions known to cause RLS were not ruled out.  The 
latter differentiation would be more important in determining 
the appropriate treatment, rather than integral in identifying 
individuals with symptomatology consistent with RLS.   
The control group subjects were selected such that they 
would not be significantly different in age from the RLS group, 
to control for possible age-related effects.  An ANOVA comparing 
the average age of the participants in the RLS group versus the 
control group showed that the two groups were not significantly 
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different in age (F [1,28] =.001, p = .971).  See Table 1 for 
descriptive statistics by group. 
Table 1.  Age of Participants by Group 
 Mean (years) Standard Deviation 
RLS 51.73 14.76 
Controls 51.93 14.99 
 
Control subjects were recruited from older undergraduate 
students at Louisiana State University, family members of 
younger undergraduates enrolled in psychology classes, and from 
age-similar associates of RLS group subjects.  Students who 
recruited a participant received extra credit towards psychology 
classes for their participation, but other subjects were not 
directly compensated for their participation. 
Basic demographic data was collected.  Tables 2-8 provide 
the results of information obtained from the questionnaire 
(shown in Appendix C) completed by the participants.   
The genders were equally distributed in the RLS group, with 
males accounting for 47% of the participant and females 
accounting for 53% of the participants.  The majority of the 
participants in the control group were female (87%).  As a 
whole, the participants were largely female (70%).  The majority 
of the RLS participants (80%) did not report any lateralization 
of symptoms (see Table 3).  Three RLS participants (20%) 
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reported that their symptoms were worse on the right side of 
their body.   
 
Table 2.  Gender of Participants by Group 
 Male Female 
 Frequency Percent Frequency Percent 
RLS 7 47% 8 53% 
Controls 2 13% 13 87% 
Total 9 30% 21 70% 
 
 
 
 
 
Table 3.  Lateralization of Symptoms 
 
Activity Frequency Percent 
No lateralization 12 80% 
Symptoms worse on the left side 0 -- 
Symptoms worse on the right side 3 20% 
 
The majority of the RLS participants indicated that the 
following activities provide relief from their symptoms: moving 
the legs (93%), getting up and walking around (87%), stretching 
the legs (80%), rubbing or massaging the legs (73%).  Few people 
reported obtaining relief from either using a heating pad/taking 
a warm bath (27%) or from applying anything cold to the legs 
(17%).  The reported location of the sensations was consistent 
with clinical descriptions.  Specifically, the majority of RLS 
participants experience symptoms in the legs (87%) and/or their 
thighs (87%).  For a detailed listing of the locations of 
symptomatology reported, see Table 5. 
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Table 4.  Proportion of RLS Subjects Indicating the Specified 
Activity Provides Relief 
 
Activity Frequency Percent 
Rubbing or massaging the legs 11 73% 
Moving the legs 14 93% 
Using a heating pad or taking a warm bath 4 27% 
Applying anything cold to the legs 2 13% 
Stretching the legs 12 80% 
Getting up and walking around 13 87% 
 
Table 5.  Location of Sensations 
 
Activity Frequency Percent 
Feet 10 67% 
Lower legs (between the ankle and the knees) 13 87% 
Thighs 13 87% 
Groin 2 13% 
Trunk 2 13% 
Shoulders or neck 7 47% 
Upper arms 4 27% 
Forearms 2 13% 
Hands or fingers 4 27% 
 
Results of questions pertaining to freq uency of sensations 
over the past 6 months illustrated the range of symptom severity 
in the RLS participants (see Table 6 and 7).  Four of the 
participants (27%) indicated experiencing their symptoms 
exclusively at night.  Only one participant (7%) reported having 
symptoms every day and one (7%) having symptoms every night. 
Table 6.  Frequency of Sensations in Legs at Night Over the Past 
6 Months 
 
Activity Frequency Percent 
One or two nights a week 3 20% 
Three or four nights a week 7 47% 
Five or six nights a week 4 27% 
Every night of the week 1 7% 
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Table 7.  Frequency of Sensations in Legs During the Daytime 
Over the Past 6 Months 
 
Activity Frequency Percent 
One or two days a week 4 36% 
Three or four days a week 5 46% 
Five or six days a week 1 9% 
Every day of the week 1 9% 
 
All of the RLS participants reported that physical activity 
relieves their symptoms and that their symptoms get worse in the 
evening.  Table 8 shows that the majority (80%) of RLS 
participants have difficulty falling asleep because of their 
symptoms.  Some of the participants indicated performing a 
physical regimen prior to attempting sleep to keep from having 
sleep onset difficulties.  Half (53%) of the participants 
reported that their symptoms are worse when they are under 
stress.  Only five of the participants (33%) had previously 
sought treatment for their symptoms.  Of those who had sought 
treatment, only one was properly diagnosed with RLS.  Half of 
the participants (53%) had been evaluated by a sleep center 
prior to participation in the current study.   
Since many persons with RLS report an increase in symptoms 
in the evening, attempts were made to have subjects participate 
in the late afternoon or early evening hours.  The late 
afternoon/evening time was preferred because of the probable 
increase in symptom severity in the evening, which could 
increase the probability of differentiating between 
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Table 8.  Other Descriptive Questions 
 
Yes No Question Frequency Percent Frequency Percent 
Do your symptoms get 
worse in the evening or 
night? 
15 100% 0 -- 
Does physical activity 
decrease or relieve your 
symptoms? 
15 100% 0 -- 
Are your symptoms worse 
when you are under 
stress? 
8 53% 7 47% 
Do you have difficulty 
falling asleep because 
of your symptoms? 
12 80% 3 20% 
Have you ever sought 
treatment for your 
symptoms of restless 
legs? 
5 33% 10 66% 
Have you ever had a 
sleep study? 8 53% 7 47% 
 
 
controls and RLS subjects.  It also controls for possible 
circadian factors.  Attempts were made to have equal numbers of 
subjects from both groups participate in the same time periods.  
The number of subjects from each group who participated anytime 
before noon versus afternoon/evening is detailed in Table 9. 
 
 
Table 9.  Participation Times of Participants by Group 
 A.M. P.M. 
 Frequency Percent Frequency Percent 
RLS 4 13% 11 37% 
Controls 7 23% 8 27% 
Total 11 37% 19 63% 
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Measuring Movement Activity 
The SIT tests were conducted at the Sleep Laboratory, 
Department of Psychology, Louisiana State University.  Subjects 
were instructed to stay awake, sit on a bed with their legs 
outstretched, and to keep their eyes open while attempting to 
remain completely still for 60 minutes.  Movement activity 
during the SITs was recorded on a Bio-Logic Systems Sleepscan 
computerized polysomnograph, which recorded anterior tibialis 
electromyogram (EMG) activity from both legs.  The EMG was 
recorded using Grass Instruments 10 mm gold-cup electrodes and 
conformed to standard electrode site placement (ASDA Atlas Task 
Force, 1993).   
Two ActiTrac actigraphs were used for each subject, with 
one being placed on the ankle of each leg.  Both recordings 
occurred simultaneously for 60 minutes.  The ActiTrac monitor 
contains a piezoelectric sensor to record physical motion.  The 
acceleration signal produced by body motion is sampled at a rate 
of 40 times per second and is digitally integrated to measure 
movement activity.  This activity is converted to data counts 
and is accumulated for each time epoch and stored in memory. 
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Experimental Hypotheses 
The following experimental hypotheses were tested: 
1. It was hypothesized that the actigraph could validly 
identify and quantify leg motor activity, as defined by 
anterior tibialis EMG. 
2. It was hypothesized that RLS subjects would have 
significantly more leg movements than control subjects on 
the SIT, as defined by both anterior tibialis EMG and 
actigraphy. 
3. It was hypothesized that the actigraphic SIT is a valid and 
effective test (as defined by Gouvier, Hayes, Smiroldo, 1998 
discussed in Part II of the Test of Experimental Hypotheses 
section) of RLS above base rates. 
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RESULTS 
Preliminary Analyses 
Pilot Testing of Actigraph Reliability.  To test the reliability 
of the actigraph recordings, a one-hour pilot testing recording 
was conducted on a single subject using three actigraphs 
simultaneously.  Two actigraphs were placed on the left ankle 
and one actigraph on the right ankle.  Three Kappa correlations 
were performed to examine the exact agreement between the 
actigraphs.  The results are shown in Table 10.  All Kappa 
statistics were significant, indicating that the actitracs were 
reliably recording the same movements.  The pilot test was 
conducted with a single subject; as such, the findings may be 
subject to bias.  Had additional subjects been employed, a wider 
range of movements may have tested the acitgraphs further and 
led to earlier identification of the recording delay discussed 
later. 
Table 10.  Kappa Statistics for Pilot Actitrac Recordings 
 Kappa Sig. 
Left Actitrac 1: Left Actitrac 2 .844 <.001 
Left Actitrac 1: Right Actitrac .770 <.001 
Left Actitrac 2: Right Actitrac .858 <.001 
 
Evaluating the Utility of Using PLM Criteria to Score Movement 
Activity.  Researchers have been inconsistent in whether or not 
PLM criteria were used to score movements during the SIT.  
Clinical descriptions of RLS and RLS research indicate that the 
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leg movements experienced by RLS patients during the day are 
both voluntary (i.e., movements deliberately initiated by the 
patient to alleviate sensory events) and involuntary.  Both 
kinds of movements have shown some evidence of periodicity.  It 
is possible that given the uncomfortable sensations commonly 
experience by those with RLS, that they would also perform a 
greater number of voluntary movements to relieve the discomfort 
than controls who do not experience this added discomfort. Thus, 
quantifying all movements may provide for larger differences 
between groups, and therefore better discrimination, as opposed 
to only using those movements meeting PLM criteria.  To examine 
this, a paired sample t-test was computed to compare the number 
of movements that conform to PLM criteria versus the total 
number of movements for both groups of subjects based on 
tibialis EMG.  Table 11 shows the average number of movements 
identified by type.  Analyses showed that significantly more 
movements were identified when all movements were counted (t[29] 
= 6.62, p<.001); however, it was observed in the current study 
that the ratio of movement activity between the groups was 
greater for PLM movements than for total movements.  In other 
words, while the average total movements for the RLS 
participants (37 movements/hour) was about three times greater 
than the average for the controls (13 movements/hour), the 
average PLMs for the RLS participants (17 PLMs/hour) was about 
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six times greater than the average for the controls (3 
PLMs/hour).  Thus, it is possible that using only the PLMs could 
in fact prove a better discriminator, and therefore a better 
classification measure, than using all movement activity.  
Analyses reported later highlight that there is actually no 
benefit, or deficiency as initially suspected, in the practice 
of counting only PLM activity.  As it made no difference which 
outcome measure was chosen, subsequent analyses are based on the 
more comprehensive measure (i.e., all movement activity), 
regardless of periodicity.   
  
Table 11.  Average Number of Movements by Group* 
Number of PLMs Other Movements All Movements  
Mean s.d. Mean s.d. Mean s.d. 
RLS 16.7 24.9 20.0 14.5 36.7 37.4
Control 3.0 4.9 9.7 6.6 12.7 10.4
Total 9.8 18.9 14.8 12.3 24.7 29.6
*Based on EMG Recording 
 
Comparing the Use of One Actigraph versus Two.  For the three 
RLS subjects reporting either some or predominantly lateralized 
symptoms, scoring of movement based on a single actigraph 
utilized the data collected on the side the individual reported 
as the source of the greatest degree of symptomatology.  For all 
control subjects and RLS participants not reporting symptom 
lateralization, single actigraph scoring of movement was based 
on the recording from the left leg.  To score the number of 
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movements identified on both actigraphs, a movement was counted 
if it occurred on either leg or both legs.   
The recording interval or epoch length (i.e., the amount of 
time represented by a data point) can be set to increments 
ranging from 2-seconds to 30-second epochs.  Thus, while the 
actigraph samples 40 times per second, the most frequent 
recording epoch is 2-seconds.  The 2-second epoch was utilized 
in the current study.  Additionally, the output from the 
actigraph can be viewed as a bar graph (as illustrated in Figure 
1) or can be exported to a Microsoft Excel worksheet (see 
partial sample output in Table 12).  A zero would indicate no 
movement activity and any number other than zero would indicate 
that movement occurred in the specified time period.  This 
approach was taken simply to make computing frequency counts 
possible.  If the raw numbers were employed, computing frequency 
counts in SPSS would have been meaningless, as all numbers would 
have been treated as a unique entity and become categories of 
activity that would be counted as often that specific number 
occurred.  Thus, to compute frequency counts, all output was 
dichotomized, with zeros indicating no movement activity and all 
other numbers being converted to ones to indicate movement 
activity.  To allow for comparisons in the current study, all 
actigraph results were first exported to a Microsoft Excel 
worksheet.   
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It was hypothesized that if some movements in the 
Kazenwadel et al. study were missed due to the use of a single 
actigraph, the use of two actigraphs might have more closely 
approximated the polygraph recordings of leg movements.  In 
the
 
Figure 1.  Sample Actitrac Bar Graph Output 
 
 
present study, the total number of 2-second epochs with movement 
recorded during the SIT for each group was computed, using the 
results from one actigraph compared to results from both 
actigraphs.  A paired sample t-test was conducted.  The analyses 
indicated that significantly more movements were identified by 
the use of two actigraphs than one actigraph (t[29] = -3.7, p = 
.001).  However, in examining the data closely, these results 
were found to be misleading.   
The actigraphs did appear to be capturing the same movement 
activity, though not at exactly the same time.  Table 12 shows 
one example of the raw output from the left and right leg 
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recording from one of the subjects.  Table 13 provides sample 
recoded output obtained from the left and right ActiTrac from a 
subject that had two movements, and illustrates the coding of 
activity based on both actigraphs.  Both the left and the right 
actigraphs recorded four 2-second epochs with movement activity, 
with each movement represented by two 2-second epochs.  However, 
in the example shown, the right actigraph is clearly “delayed” 
in logging the movement compared to the left actigraph.  Thus, 
while both actigraphs were properly logging movement activity, 
they were not logging the same movement at the exact same point 
in time according to the output.  This lack of synchronization 
in timing results in overestimating movement activity when 
recoding the information to quantify activity from both 
actitracs.   
It should be stated that the delay was clearly not 
attributable to any true delay in movement activity between one 
leg and the other leg.  In other words, it was not possible that 
the delay identified was due to a participant moving one leg and 
later moving the other leg.  The identified delays were 
consistent within a participant’s recording.  The partial sample 
output in Table 12 illustrates two successive movements on each 
leg, with the “movement” on the right leg appearing eight 
seconds later than the left.  If the whole output were shown, 
one would see that every time movement activity occurred on the 
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Table 12.  Sample Actigraph Output in Microsoft Excel 
Time Left Actigraph Right Actigraph 
6:23:54 PM 10.3 0 
6:23:56 PM 1.6 0 
6:23:58 PM 0 0 
6:24:00 PM 0 0 
6:24:02 PM 0 4.7 
6:24:04 PM 0 0.9 
6:24:06 PM 0 0 
6:24:08 PM 0 0 
6:24:10 PM 0 0 
6:24:12 PM 0 0 
6:24:14 PM 0 0 
6:24:16 PM 0 0 
6:24:18 PM 0 0 
6:24:20 PM 0 0 
6:24:22 PM 0 0 
6:24:24 PM 0 0 
6:24:26 PM 3.7 0 
6:24:28 PM 0.9 0 
6:24:30 PM 0 0 
6:24:32 PM 0 0 
6:24:34 PM 0 0.3 
6:24:36 PM 0 0.3 
6:24:38 PM 0 0 
6:24:40 PM 0 0 
 
left leg, there would be movement logged on the right actigraph 
exactly eight seconds (or four 2-second epochs) later.  The 
duration of the delay was highly consistent within subjects, but 
not at all consistent across subjects, ranging from 2 seconds to 
just over 30 seconds.  The duration of delay could not be 
determined for those participants with almost no movement 
activity or those with a significant amount of movement 
activity, because it was not possible to identify a consistent 
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Table 13.  Sample Recoding of Actigraph Output 
Time Left Actigraph 
Right 
Actigraph 
Both 
Actigraphs 
6:23:54 PM 1 0 1 
6:23:56 PM 1 0 1 
6:23:58 PM 0 0 0 
6:24:00 PM 0 0 0 
6:24:02 PM 0 1 1 
6:24:04 PM 0 1 1 
6:24:06 PM 0 0 0 
6:24:08 PM 0 0 0 
6:24:10 PM 0 0 0 
6:24:12 PM 0 0 0 
6:24:14 PM 0 0 0 
6:24:16 PM 0 0 0 
6:24:18 PM 0 0 0 
6:24:20 PM 0 0 0 
6:24:22 PM 0 0 0 
6:24:24 PM 0 0 0 
6:24:26 PM 1 0 1 
6:24:28 PM 1 0 1 
6:24:30 PM 0 0 0 
6:24:32 PM 0 0 0 
6:24:34 PM 0 1 1 
6:24:36 PM 0 1 1 
6:24:38 PM 0 0 0 
6:24:40 PM 0 0 0 
 
trend for the delay.  There was no “correction factor” that 
could be consistently applied either individually or across 
participants to offset this technical problem 
After this delay was identified, the company that developed 
the ActiTrac monitors was contacted and provided the data.  The 
technical support personnel indicated that there was a flaw with 
the software used to set the actigraphs to begin recording at 
the same time.  Even when new software was obtained, the 
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Table 14.  Sample Recoding of Pilot Subject Movements 
Time Left Actigraph 
Right 
Actigraph 
Both 
Actigraphs 
14:37:02 0 0 0 
14:37:04 0 0 0 
14:37:06 0 0 0 
14:37:08 0 0 0 
14:37:10 0 0 0 
14:37:12 0 0 0 
14:37:14 0 0 0 
14:37:16 1 0 1 
14:37:18 1 0 1 
14:37:20 1 1 1 
14:37:22 1 1 1 
14:37:24 1 1 1 
14:37:26 1 1 1 
14:37:28 1 1 1 
14:37:30 1 1 1 
14:37:32 1 1 1 
14:37:34 1 0 1 
14:37:36 1 1 1 
14:37:38 1 1 1 
14:37:40 0 1 1 
14:37:42 0 0 0 
14:37:44 0 0 0 
14:37:46 0 0 0 
14:37:48 0 0 0 
 
delay was still apparent.  During further communication with the 
developers of this device, it became clear that the ActiTrac had 
not been designed to be accurate down to the exact second.  
Testing after the completion of the study identified the source 
of the delay and is described in the discussion section. 
Because of the inability of the ActiTrac to log movements 
at the exact point of time that the movement occurs, using the 
results from both actigraphs would greatly inflate the number of 
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2-second epochs in which movements were identified.  
Consequently, subsequent analyses are based on the use of one 
actigraph.   
Because the actigraphs were not logging movements at 
exactly the same time relative to each other, it could no longer 
be assumed that the actigraphs were logging movement at the 
exact same time as the EMG recording.  Recordings were taken 
from both the actigraph and tibialis EMG simultaneously in order 
to compute exact agreement between these two recording methods.  
Though the variable recording delay rendered this statistic 
invalid, and it would have been ideal to perform this 
calculation, this problem did not represent a major limitation 
to the current study as long as the actigraphs were still 
capable of documenting movement activity, as they were.  While 
it was impossible to perform Kappa for exact agreement between 
these recording methods, it did not interfere with calculating 
the ability of the actigraphs to distinguish between RLS and 
control subjects, which is discussed later.  Instead of 
computing Kappa for exact agreement, a Pearson correlation could 
still be computed between the total number of two-second epochs 
with movement identified by the EMG recording versus the number 
of two-second epochs with movement identified by the actigraph 
recording to provide some documentation of the association 
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between these recording methods.  There was a significant 
positive correlation (r=0.7, p<.001) between these two indices.   
The original research plan was to perform analyses based on 
the number of actual discrete movements.  The latter proved 
impossible because the most frequent output from the actigraph 
is whether or not there was any movement in a given two second 
period.  This is a limitation of the actigraph when compared to 
the continuous recording of EMG activity.  A number of the 
movements occurred in close proximity, which is easy to 
distinguish on the EMG recording, but not in the actigraph 
output.  Figure 2 provides an illustration of this finding.  
Note in the figure that the EMG recording clearly documents 
multiple, discrete movements.  In reviewing the actigraph 
output, it is impossible to distinguish between multiple 
movements in close proximity versus one or two long movements.  
However, there was an important benefit of using two-second 
epochs as the outcome measure.  Counting the number of movements 
does not take into account the duration of a movement, which is 
approximately accounted for when counting each 2-second time 
period with movement activity.  Thus, each method has its 
advantages and limitations, and either one can address the 
experimental hypotheses of this investigation. 
Additionally, one of the proposed advantages of developing 
an actigraphic method for objectively identifying persons with 
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RLS was that it would be faster and require less staff time than 
an EMG evaluation.  However, attempting to count discrete 
 
 
 
 
 
 
 
 
Figure 2.  Comparison of EMG and Actigraph Recording using 2-
second epochs 
 
movements on the actigraph output as originally planned actually 
would have required more time than counting movements based on 
the EMG recording.  Fortunately, changing the outcome measure to 
number of 2-second epochs with movement, as required by the 
limitations of the ActiTrac, turned out to be significantly 
faster than examining the EMG recording. 
Test of the Experimental Hypothesis 
Differentiating RLS from Normal Subjects.  To examine the 
diagnostic utility of a measure such as the SIT, there are a 
number of statistics that can be computed.  The performance of a 
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test can be quantified in terms of its sensitivity, specificity, 
positive predictive power, negative predictive power, and the 
overall correct classification rate.  Following is a description 
of how each of these terms is defined and was calculated for the 
current study, based on Kessel and Zimmerman (1993).  Appendix A 
provides the computational formulas employed. 
Before these statistics were computed, there was an 
important consideration: What cutoff score should be employed to 
determine whether an individual’s results were consistent with, 
or diagnostic of, RLS or not?  In determining whether or not an 
individual has a condition or not on the basis of a continuous 
variable, in this case the number of 2-second epochs with 
movement activity during the SIT, the sensitivity and 
specificity of the measure would depend on where the cutoff 
between a positive and negative test result was set.  One method 
utilized to display the association between sensitivity and 
specificity for tests that have continuous outcomes is with 
receiver operator characteristic curves (ROC curves).  ROC 
curves plot the sensitivity against specificity minus 1.  ROC 
curves also provide a useful means of comparing two diagnostic 
tests.   
The ROC curve was plotted for the actigraph to determine 
the cutoff score that would result in the highest combination of 
sensitivity and specificity that could be used to determine 
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whether an individual’s SIT results were consistent with RLS or 
not (see Figure 3).  The ROC curve test statistic indicated that 
the cut-off score that should be employed to maximize 
sensitivity and specificity was 82 two-second epochs with 
movement/hour.  The reference line illustrates a test that is no 
better than chance.  The closer an ROC curve is to the upper 
left-hand corner of the graph, the more accurate it is, because 
the sensitivity and specificity approach 100%.   Complete 
detailed explanations of the use and meaning of ROC curves are 
have been published (e.g., Begg, 1991; Hanley & McNeil, 1982; 
Hanley & McNeil, 1983; Thompson & Zucchini, 1989).   
The corresponding sensitivity, specificity, false-positive rate, 
false-negative rate, positive predictive value, and negative 
predictive value calculated given this cut-off score are 
detailed in Table 15.  Sensitivity is the ability of a test to 
accurately identify individuals who have a condition as having 
the condition.  For the present study, sensitivity was60% and 
was computed by dividing the number of RLS patients accurately 
identified by actigraphy (i.e., true-positives) by the total 
number of RLS patients.  Specificity is the ability of a test to 
accurately identify those who do not have the condition as not 
having the condition (i.e., true-negatives).  Specificity was 
73% and was computed by dividing all of the control subjects 
identified as not having RLS by the total number of controls.  
  43
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.  ROC Curve Based on Actigraph 
 
False-negatives are the number of individuals incorrectly 
identified as not having the condition.  In the present study, 
the false negative rate was 40% and was computed by dividing the 
number of individuals incorrectly identified as not having RLS 
by all subjects with a positive test result.  The false-positive 
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Table 15.  Test Characteristics of the SIT Using Number of 2-
Second Epoch with Movement on Actigraph Recording 
 
Diagnosis 
Test Positive Negative  
Positive 9 A B 4 
 
Negative 6 C D 11  
True Positive/Sensitivity = 60% 
True Negative/Specificity = 73% 
False Positive = 27% 
False Negative = 40% 
Positive Predictive Power = 69% 
Negative Predictive Power = 65% 
Overall Correct Classification = 67% 
Valid if (9/4)> (6/11); Actigraphic SIT 
valid 
Test is effective only if base rate is > 33% 
 -Screening: 5% is not > 33%; Not 
effective for screening 
 -Clinical: 9% is not > 33%; Not 
effective for use in clinical setting 
 
The positive predictive value of a test indicates the 
probability that an individual will be correctly identified as 
having a condition, given a positive indication on the test.  In 
the present study, it was computed by dividing all of the true-
positives by all individuals with positive test results.  The 
negative predictive value of a test indicates the probability 
that an individual will be correctly identified as not having a 
condition, given a negative test result.  It was computed in the 
present study by dividing the number of true-negatives by all 
subjects with negative results.  The positive predictive value 
and negative predictive value were 69% and 65% respectively. 
  45
Last, the overall accuracy, or overall correct 
classification rate, refers to the proportion of individuals 
correctly identified as having a condition or not.  This was 
computed by dividing the combined total of true-positives and 
true-negatives by the total number of tests performed.  Two 
thirds of the participants (67%) were correctly classified using 
actigraphy. 
An additional factor was considered before making a final 
determination as to the usefulness of the actigraphic SIT to 
discriminate between those with RLS and controls.  Specifically, 
the base rate of RLS, and how that related to the utility of the 
SIT as a diagnostic test, was examined.  Thorough explanations 
of the association between base rates the interpretation of a 
test result has been published (e.g., Gouvier, Hayes, Smiroldo, 
1998; Hayes, Hilsabeck, Gouvier, 1999; Pinkston, 1998).  Base 
rates refer to the current population prevalence of a condition, 
and can be determined by dividing the number of persons with the 
condition by the number of persons in the population of 
interest.  In other words, base rate is the prior probability 
that an individual has a specific condition, regardless of the 
outcome of a test.  A test is considered a valid indicator if 
the sensitivity (60%) divided by the false positive error rate 
(27%) is greater than the false negative error rate (40%) 
divided by specificity (73%).  The actigraphic SIT was found to 
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be valid (see Table 15).  However, a test is not considered 
effective unless the classification rate of the test is superior 
to classification based on base rates alone.  In order for a 
test to be an effective tool for a clinician, the combined error 
rates of the test (i.e., false positive rate plus false negative 
rate) should be less than the base rate of the condition.  
Otherwise, a clinician would be more accurate overall in making 
judgments using base rates alone.  This description applies only 
when the base rate of the condition is less than 50%, as with 
the current study; an alternate formula is utilized when the 
base rate exceeds 50%.   
The effectiveness of a test can depend on the base rate 
employed.  For example, if one were interested in using the SIT 
test as a screening tool to evaluate all persons in the 
population for RLS, you would use population prevalence as the 
base rate.  Current prevalence studies indicate that RLS exists 
in approximately 5% of the population.  On the other hand, if 
you want to evaluate effectiveness of the SIT test as a 
diagnostic test on persons presenting to a sleep laboratory, one 
would use the prevalence of RLS among those presenting to the 
sleep laboratory.  There are no published data indicating the 
prevalence of RLS in persons presenting to sleep laboratories.  
However, a review of 100 sequential referrals to the Baton Rouge 
General Medical Center Sleep Disorders Center indicated a 
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prevalence or base rate of 9%.  Thus, the effectiveness of the 
SIT test was computed using both of the identified base rates to 
evaluate the effectiveness of this test for each purpose. Given 
the combined error rates for the SIT (33%), the test was not 
found to be effective for either screening (assuming 5% 
prevalence) or for use clinically (assuming 9% prevalence). 
To examine this possibility, all of the test 
characteristics were recomputed using number of PLMs as the 
dependent variable for the SIT.  ROC curves were completed, 
which indicated a cutoff of 2 PLMs/hour provides the greatest 
combined sensitivity and specificity.  The calculated test 
characteristics are shown in Table 16.  There were a few 
differences when using PLMs rather than the number of 2-second 
epochs on the actigraph.  The specificity declined slightly due 
to one less control being accurately identified, decreasing the 
overall correct classification slightly to 63%.  Similar to the 
result using actigraphy recordings, this measure did not prove 
to be effective for either a screening or a diagnostic tool.  
As an additional means of comparing the EMG recording to 
the actigraph recording, these test characteristics were 
computed using the total number of movements identified on the 
EMG recording, using a cutoff score of 17 movements/hour 
obtained with an ROC curve.  The results are shown in Table 17. 
The sensitivity and specificity improved slightly due to one 
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Table 16.  Test Characteristics of the SIT Using Total PLMs 
Based on EMG Recording 
 
Diagnosis  
Test Positive Negative  
Positive 9 A B 5 
 
Negative 6 C D 10  
True Positive/Sensitivity = 60% 
True Negative/Specificity = 67% 
False Positive = 33% 
False Negative = 40% 
Positive Predictive Power = 64% 
Negative Predictive Power = 63% 
Overall Correct Classification = 63% 
Valid if (9/5)> (6/10); EMG SIT using PLMs valid 
Test is effective only if base rate is > 37% 
 -Screening: 5% is not > 37%; Not effective 
for screening 
 -Clinical: 9% is not > 37%; Not effective 
for use in clinical setting 
 
additional control and RLS participant being accurately 
identified, increasing the overall correct classification 
slightly to 70%.  The ROC curves for each of these three 
possible outcome measures can be visually compared using Figure 
4.   
Last, the diagnostic classification status indicated by the 
actigraph versus the EMG recording was compared and the Kappa 
statistic was calculated to indicate the agreement between these 
two measures.  The Kappa value was moderate, though 
statistically significant from zero (0.4, p<.05). 
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Table 17.  Test Characteristics of the SIT Using Total Movements 
Based on EMG Recording 
 
Diagnosis  
Test Positive Negative  
Positive 10 A B 4 
 
Negative 5 C D 11  
True Positive/Sensitivity = 67% 
True Negative/Specificity = 73% 
False Positive = 27% 
False Negative = 33% 
Positive Predictive Power = 71% 
Negative Predictive Power = 69% 
Overall Correct Classification = 73% 
Valid if (10/4)> (5/11); EMG SIT valid 
Test is effective only if base rate is > 27% 
 -Screening: 5% is not > 27%; Not 
effective for screening 
 -Clinical: 9% is not > 27%; Not effective 
for use in clinical setting 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.  Comparison of ROC Curves 
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DISCUSSION 
Due to unexpected technical limitations of the actigraph 
recordings, an index of exact agreement (i.e., moment-to-moment, 
Kappa) between tibialis EMG and actigraphy measures was not 
possible, though a more general index of agreement (i.e., 
Pearson) was possible.  There was a statistically significant 
positive correlation between EMG and actigraph measures of 
movement.  The described technical problem, which appeared to be 
a variable recording initiation lag (across subjects), led to 
systematic testing of several factors, such as changes in the 
intensity and duration of movements, as well as changes in the 
initialization process of the two ActiTracs utilized in the 
current study, to find any possible explanation for the “delay”.   
Initializing the actigraph involves plugging a specialized 
cable provided with the devices (connected to a port in a 
computer) into the actigraph and starting the device’s software 
program.  The program provides the experimenter the opportunity 
to set the output frequency of the device, delineate a name for 
the file that will be generated, and to set a delayed recording 
time if desired.  The user’s manual for the ActiTracs used in 
the current study states that after the initialzation process is 
completed for a unit that has a delayed recording time 
specified, that the unit “will go to ‘sleep’ until the specified 
date and time, at which time it will ‘wake up’ and begin 
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recording”.  Given this information, the experimenter had 
initialized the ActiTracs to each delay the recording time, but 
with the same specified future time.  For example, if a SIT was 
to begin at 6:30 p.m., the experimenter initialized the first 
actigraph with setting a delayed recording time at 6:30 p.m., 
disconnected the first device, and then initialized the second 
actigraph with the same delayed recording time (6:30 p.m.).  The 
actigraphs were taped to a small board; the experimenter 
simulated activity by moving the board.  Attempts were made to 
characteristics about the simulated movements, such as the speed 
of a simulated movement (e.g., short, slow movements; short, 
rapid movements; long, fast movements), as well as the interval 
between the simulated movements. 
The test data revealed that the ActiTracs were not properly 
delaying the beginning of the recording to correspond to the 
time specified by the user.  The ActiTracs were in fact 
beginning recording at the end of the initialization process, 
not at the programmed start time.  The time of completion of the 
initialization process was different between the two actigraphs 
(as only one could be initialized at time), which accounts for 
the different “delay” across participants.  The problem was 
tested by varying the interval between the completion of the 
initialization process and the delayed start time, with short 
periods of activity subsequently simulated on the actigraph, and 
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the time the actigraph logged those movements noted.  For 
example, on one test trial, the initialization was done at 
7:18:44 pm, the start time specified for 7:20:00 p.m., and the 
first test movement done at 7:20:10 p.m., the ActiTrac logged 
this movement at 7:21:26 p.m., 1 minute 16 seconds later than it 
actually occurred.  The time between initialization and the 
actual movement was 1 minute 16 seconds, but the time between 
the programmed (and actual) start time and the movement was only 
10 seconds.  The data thus show that the ActiTrac began 
recording at the time of initialization instead of the 
programmed time, but labeled that initial epoch as the 
programmed start time; this means that the data included the 
time between initialization and the programmed start time (the 
start of the SIT), when it should have only included data from 
the programmed start time and the start of the SIT (actually, 
the same time).  Hence the delay. This outcome was repeatedly 
found over 8 independent test trials on each of the two 
ActiTracs used in this investigation. 
Testing also evaluated if the ActiTracs were logging the 
duration of movements accurately, if they were properly logging 
the interval between movements, and what intensity of movement 
was necessary to be logged.  During the 16 test trials (8 for 
each ActiTrac), movements of duration varying between 1-10 
seconds were simulated.  Each time a movement was simulated, the 
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duration and clock time at the start of the simulated movement 
was noted.  The interval between simulated movements was also 
varied from 10-60 seconds.  The notations were then compared to 
the duration of movements and interval between movements 
identified on the actigraph output.  Testing revealed that the 
movements were being logged at the accurate time (from the time 
of initialization), were being logged for the approximate 
duration consistently, and consistently logged the inter-
movement interval.  For example, on trials in which a 6 second 
movement was simulated, the actigraph output consistently showed 
either three or four two-second epochs with movement (the 
approximate agreement due to such factors as human reaction 
time).  Also, attempts were made to alter other characteristics 
about the simulated movements, such as the speed of a simulated 
movement (e.g., short, slow movements; short, rapid movements; 
long, fast movements).  It proved difficult to simulate a 
movement that the actigraph would not log.  In other words, the 
actigraphs appeared to be sensitive enough to pick up a wide 
range of intensity of movements. 
The above described technical problems with programming a 
delayed start support the decision that statistics such as Kappa 
would not have been appropriate, as the units were truly not 
beginning to record at the same time, despite the output 
indicating they were doing so.  Obviously there is a flaw in the 
  54
software used to initialize the actigraphs.  The beginning 
portion each participants recording time, therefore, corresponds 
to differences in the time to set up the equipment (i.e., 
initialize the actigraph).  Given the relatively small delays 
identified (when the delay could be identified) this would 
unlikely result in significant changes in the current findings.  
However, clearly future studies such as this should not be 
undertaken until the true nature of the actigraphy is better 
tested to ensure it’s validity. 
There was significantly more movement during the SIT than 
activity meeting PLM criteria.  It initially appeared that 
previous studies using only PLM activity were too limiting 
(Brodeur et al., 1988; Pelletier et al., 1992; Montplaisir et 
al., 1998); evaluation of test characteristics showed that this 
index was neither too limiting nor additionally beneficial.  In 
other words, using a count of the PLMs during the SIT was no 
better or worse than using all movement activity.  One of the 
PLM criteria in particular, a maximum duration of 4 seconds, 
would result in several of the longer voluntary movements not 
being counted.  However, the analyses of subsequent test 
characteristics did not indicate that an actigraphic SIT would 
be an effective diagnostic tool for either screening or clinical 
purposes, either when all movement activity was counted, when 
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PLM activity only was counted, or when tibialis EMG was used 
instead of actigraphy.   
Surprisingly, many of the persons with RLS who ultimately 
participated in this study had never heard of this disorder.  
Only 2 of the 15 RLS participants (13%) knew of RLS prior to 
participating in the current study, even though 5 of the 
participants had sought treatment for their symptoms previously 
and 8 had had a sleep study previously.  Only 1 of the 5 
participants who sought treatment specifically for symptoms 
consistent with RLS were properly identified as having RLS.  
Physicians do not appear to be identifying RLS, which is a 
significant public health education issue.  In addition, 
inadequate recognition of RLS has significant implications for 
previously estimated prevalence rates of RLS.  Overall, studies 
examining the prevalence of RLS in the general population have 
found that the population prevalence of RLS is approximately 5%.  
Recent studies have indicated that the prevalence may be as high 
as 15% (Lavigne & Montplaisir, 1994), though some studies have 
estimated prevalence on the basis of a single telephone survey 
question.  Clearly one isolated question would not provide 
adequate evidence of whether or not a person has RLS, which to 
be properly diagnosed requires multiple indicators.  As most of 
the participants had not been identified as having RLS prior to 
enrolling in the current study, the need for public education is 
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evident, and the possibility that the 5% rate used in the 
current study underestimates the actual prevalence rate of RLS 
must be considered in interpreting the clinical utility of the 
findings. 
The current study does not support the clinical use of an 
actigraphic SIT using the methodology described.  In fact, the 
sensitivity and specificity found in the current study is 
somewhat lower than that found by Montplaisir and fellow 
researchers (1998), who also examined the diagnostic utility of 
the SIT using polygraph EMG recordings.  Many of the initial 
studies examining the SIT were testing the utility of a 
particular medication to treat RLS (e.g., Brodeur et al., 1988).  
Persons with RLS seeking medical treatment are likely in the 
severe range, though most studies do not report any indicators 
of symptom severity, such as frequency of symptoms.  The current 
study recruited participants from the entire range of symptom 
severity.  While this sample would better allow for evaluating 
the SIT as a diagnostic and screening tool, it is also likely 
the key reason the SIT proved less discriminating than in prior 
research.  The possibility of an actigraphic SIT to objectively 
measure RLS symptomatology should not be ruled out; changes in 
SIT procedures and actigraph outcome variables may be all that 
is needed to attain an effective actigraphic SIT, regardless of 
symptom severity.  Additionally, the current study utilized one 
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outcome measure to discriminate between RLS and control 
participant; future studies could examine other objective and 
subjective variables in combination with SIT outcome would 
improve on the sensitivity and specificity found in the current 
study.  Also, the cutoff score utilized in the current study did 
provide for the highest combined sensitivity and specificity.  
The cutoff score employed could be altered to maximize 
sensitivity (i.e., accurately identify a larger proportion of 
RLS persons), if one were willing to accept a higher rate of 
false positives.  For example, this practice could lead to a 
tiered approach in a screening process in which a larger 
proportion of persons could be initially identified as possibly 
having RLS (likely including the majority of people who truly 
have RLS) by using a lower cutoff score, which could be then 
followed up by interviewing to exclude higher rate of false 
positives that would be generated by the use of a lower cutoff 
score. 
One possible alteration in SIT procedures that could be 
evaluated in future studies would be whether or not establishing 
a standardized recording time in the evening would enhance the 
diagnostic accuracy of the test.  The latter would capitalize on 
the worsening of symptom severity experienced in the evening by 
most persons with RLS.  Additionally, given the variable nature 
of RLS, these participants may not experience symptoms on the 
  58
day a single SIT is performed.  It is possible that performing 
serial SITS would capture at least one or more days of symptom 
activity, and using the combined information would allow for 
superior discrimination over controls, who would not be expected 
to have significant day-to-day changes in SIT outcome.   
Advancements in actigraph technology may also correct some 
of the problems encountered.  It would be beneficial if 
actigraphs were capable of providing output on a frequency 
greater than every 2 seconds, which would make it easier to 
identify and count discrete movements and would more closely 
approximate EMG recording.  Last, it would be useful to evaluate 
changes in the directions for the SIT.  Some of the RLS 
participants did not have much movement activity.  During 
discussion afterwards, some such participants indicated they did 
not have symptoms during the SIT; however, others reported that 
they were uncomfortable but were able to exert significant self-
control over their movements and thus limited their movement 
activity despite their discomfort.  Changes in the standard 
instructions could reduce the likelihood that lack of movement 
is due to the ability of an individual to resist movement even 
while withstanding significant discomfort.   
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APPENDIX A:  COMPUTATIONAL FORMULAS FOR EVALUATING TEST 
CHARACTERISTICS 
 
Diagnosis 
Test Positive Negative  
Positive A B  
Negative C  D  
True Positive/Sensitivity = A/ (A + C) 
True Negative/Specificity = D/ (B + D) 
False Positive = B/ (B + D) 
False Negative = C/ (A + C) 
Positive Predictive Power = A/(A + B) 
Negative Predictive Power = D/(C + D) 
Overall Correct Classification = (A + D)/N 
Valid = (A/B)> (C/D) 
Effective if base rate > (B + C)/N 
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APPENDIX B:  CONSENT FORM 
 
1.   Study Title:     
 Use of actigraphy in restless legs syndrome 
 
2.   Performance Sites:    
 Louisiana State University, Audubon Hall 
                                   
3.   Contacts:   The following investigators are available for 
questions at the phone numbers listed below. 
   
Investigators: Phone Number: Times Available: 
William F. Water 225-578-8745 Monday 10-1; 
Tuesday 10-5 
Tai A. Istre 504-568-3068 Monday-Friday, 9-5 
 
4.   Purpose of the Study:  The goal of the current study is to 
evaluate whether two different tests can assess leg muscle 
activity the same. The tests being used in the study may 
help in diagnosing individuals with a sleep disorder called 
restless legs syndrome. 
 
5.   Subjects:  
      
 A.  Inclusion Criteria:  Subjects must be at least 18 years 
old to participate.  In order to be included, participants 
must meet criteria for restless legs syndrome or must be 
close in age to a participant who has restless legs 
syndrome. 
 
B.  Exclusion Criteria:  Persons younger than 18 years old.   
 
 C.  Maximum number of subjects: 30  
   
6. Study Procedures:  All participants will be asked to provide 
descriptive information such as their age, gender, and 
symptoms of restless legs syndrome. During the study, 
participants will be need to stay awake, sit on a bed with 
their legs outstretched, and to keep their eyes open while 
attempting to remain completely still for 60 minutes.  Each 
participant will have four electrodes placed on their lower 
leg, two on each leg, which will measure how much they move 
their legs.  Participants will also have an actigraph (a 
small device that looks like a wrist watch) placed on each 
ankle, which will also measure how much they move their 
legs.  The study will take approximately one and a half 
hours to complete.  
     
7. Benefits: The study will not benefit subjects directly.  The 
current study may provide an easy test that would be helpful 
in diagnosing Restless Legs Syndrome in the future. 
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8. Risks/Discomforts:  The risks are very small, and include a 
small possibility of developing mild skin irritation where 
recording devices are attached to the skin. Persons with 
Restless Legs Syndrome who withdraw from medications being 
used to treat their disorder may have a return of their 
symptoms the day they abstain from their medication.  
Participants may experience discomfort while attempting to 
keep their legs completely still.  Though participants will 
be asked to keep as still as possible, they can move their 
legs if necessary to help decrease any discomfort.   
 
9. Measures taken to reduce risk:  Participants who will be 
abstaining from their medications related to their Restless 
Legs Syndrome will be doing so under the supervision of 
their physician. 
 
10. Right to Refuse:  Participation in the study is voluntary 
and participants may change their mind and withdraw from the 
study at any time without penalty.   
 
11. Privacy:  The results from the study may be published as 
group data in which no subjects’ results are presented 
individually.  The privacy of participating subjects will be 
protected and the identity of participants will not be 
revealed.  The data collected will not be used for any 
purpose not approved by the participants and the LSU 
Institutional Review Board.   
             
12. Financial Information:  There will be no monetary 
compensation for participation in the study. 
 
13. Withdrawal:  Participants may withdrawal from the study at 
any time by telling the investigator at any time. 
              
14. Removal:   Restless Legs Syndrome participants who do not 
abstain from medication prescribed for the treatment of 
this condition or who do not obtain written permission from 
their doctors to do so will not be able to participate. 
 
15. Signatures:  The study has been discussed with me and all 
my questions have been answered. I may direct additional 
questions regarding study specifics to the investigators. 
If I have questions about subjects' rights or other 
concerns, I can contact Robert c. Mathews, Chairman, LSU 
Institutional Review Board, (225)578-8692. I agree to 
participate in the study described above and acknowledge 
the researchers’ obligation to provide me with a copy of 
this consent form if signed by me. 
 
 
_______________________Participant Signature ____________ Date 
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_______________________Witness Signature _____________ Date 
 
_______________________Investigator Signature ___________ Date 
 
 
The study subject has indicated to me that he/she is unable to 
read. I certify that I have read this consent form to the subject 
and explained that by completing the signature line above, the 
subject has agreed to participate. 
 
_______________________Signature of Reader ___________ Date 
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APPENDIX C:  RESTLESS LEGS SYNRDOME QUESTIONNAIRE 
 
1. Do you ever have uncomfortable sensations in your legs? 
? Yes 
? No (if not, skip to question #24) 
 
2. Please describe the sensations in your legs as best you can: 
 
 
 
 
3. At what times do you get the symptoms? 
 
 
 
4. Do your symptoms get worse in the evening or night? 
? Yes 
? No 
 
5. What do you do when you get the symptoms? 
 
 
 
 
6. Does physical activity decrease or relieve you symptoms? 
? Yes 
? No (if not, you make skip to question #8) 
 
7. Which of the following activities are helpful in relieving 
your symptoms? (check all that apply) 
? Rubbing or massaging your legs 
? Moving your legs 
? Using a heating pad or taking a warm or hot bath 
? Applying anything cold to the legs 
? Stretching your legs 
? Getting up and walking around 
? Other (please describe): 
_______________________________________________ 
 
8. How old were you when you first began to get the symptoms?  
_________ years old 
 
9. Have there been periods of time when the symptoms got better 
or worse or even went away completely?  Describe. 
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10. Are there any things that seem to make your symptoms better 
or worse? Please describe. 
 
 
 
 
11. Are your symptoms worse when you are under stress? 
? Yes 
? No 
 
12. How often have you had the sensations in your legs over the 
past 6 months? 
? One or two nights a week 
? Three or four nights a week 
? Five or six nights a week 
? Every night of the week 
 
13. Do you also get the sensations in your legs during the day?  
If yes, please note how often you have had them over the last 
6 months. 
?  One or two days a week 
? Three or four days a week 
? Five or six days a week 
? Every day of the week 
 
14. Please use the list below to indicate where the sensations 
occur? (check all that apply) 
? Feet 
? Lower legs (between the ankle and knee) 
? Thighs 
? Groin 
? Trunk 
? Shoulders or neck 
? Upper arms 
? Forearms 
? Hands or fingers 
 
15. Are your symptoms worse on one side? 
? No, it is the same on both side of my body 
? Yes, the symptoms are worse on the left side 
? Yes, the symptoms are worse on the right side 
 
16. Use the rating scale below to indicate how severe your 
restless legs symptoms usually are: 
1 2 3 4 5 6 7 
Mild      Severe 
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17. Do you have difficulty falling asleep because of your 
symptoms? 
? Yes 
? No 
 
18. When you experience symptoms of restless legs, how long 
does it take you to fall asleep (on average)? ___________ min. 
 
19. When you do not experience symptoms of restless legs, how 
long does it take you to fall asleep (on average)? 
_______________ minutes 
 
20. Have you ever sought treatment for you symptoms of restless 
legs? 
? Yes 
? No (skip to question #22) 
 
21. What treatment or medication did your doctor prescribe? 
 
 
 
22. How effective was the treatment? 
 
 
 
23. Have you ever had a sleep study (Polysomnogram) done? 
? Yes 
? No 
 
24. What is your date of birth? 
 
25. Gender: 
? Male 
? Female 
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